Date of Conferral

2022

Degree

Ph.D.

School

Public Health

Advisor

Carla G. Riemersma

Abstract

Diabetes is a long-lasting chronic health condition that encompasses three types: Type 1, Type 2, and gestational diabetes. The disease affects how the body breaks down food into energy. It is an insulin-deficient disease and causes heart disease, vision loss, and kidney disease. Investigators of the Centers for Disease Control and Prevention and the American Diabetes Association evaluated patient treatment preferences to determine the upsurge in patient health-related quality of life (HRQOL) and optimum health. The literature revealed that patients' preferences consisted of therapies and achievable goal setting using the health belief model (HBM) framework. This quantitative research aimed to predict therapies in diabetes management measured by PROMIS 25 (instrument) for patients with Type 2 diabetes. The generated data were analyzed using Statistical Package for Social Sciences (SPSS, Version 24) t test, ANCOVA for significant differences in therapy groups with statistical significance set at p<0.05, multivariate logistic regression analysis, Spearman's correlation for the strength and direction of monotonic association between two variables, and possible bivariate analysis to examine associations of concomitant factors. The outcomes from therapy preferences were analyzed using PROMIS 25 mean scores (i.e., managed confidence (Well-being), p= control symptoms of anxiety (HRQoL), across subgroups, assessed the individual self-efficacy of HRQoL, and Well-being probability, and in the same manner, of optimum and general health outcomes. Social change that increased the patient's willingness to participate in therapies that increased the HRQoL and well-being revealed in the HBM outcome increased patients' positive engagement in lifestyle behaviors that reduced risk.

Download

Share

 
COinS